Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ferenc Czeglédi"'
Autor:
Judit Kralovánszky, Vilmos Adleff, Barna Budai, Miklós Kásler, István Láng, Zsolt Orosz, Fruzsina Gyergyay, Zsolt Horváth, Ferenc Czeglédi, Tibor Kovács, Erika Hitre, József Lövey
Publikováno v:
Pharmacogenetics and Genomics. 15:723-730
The present study aimed to prospectively investigate the influence of thymidylate synthase (TS) polymorphisms (5'-TSER, 3'-TSUTR) on the disease-free survival (DFS) and overall survival (OS) of patients with colorectal cancer (CRC) who were treated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905b6cea043c4e93799b83bc8ecd9978
https://doi.org/10.1097/01.fpc.0000175598.42141.59
https://doi.org/10.1097/01.fpc.0000175598.42141.59
Autor:
István Láng, Miklós Kásler, Sándor Eckhardt, Laszlo Torday, Csaba Polgár, Erna Ganofszky, Zsolt Horváth, Eva Juhos, László Urbán, Erika Hitre, Ferenc Czeglédi
Our retrospective analysis compared the effectiveness of conventional antracycline-containing protocols (A+) and docetaxel/epirubicine (TE) as primary systemic chemotherapies (PSCT) for inflammatory breast cancer (IBC). Seventy IBC patients received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::394f3967cf1ccdb28fedd98bf15c91d7
Autor:
Barna, Budai, Erika, Hitre, Vilmos, Adleff, Ferenc, Czeglédi, Fruzsina, Gyergyay, István, Láng, Judit, Kralovánszky
Publikováno v:
Magyar onkologia. 48(3)
The authors investigated the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in 101 metastatic colorectal cancer patients treated with 5-fluoropyrimidine-based therapy and in 196 healthy individuals by PCR-RFLP method. There was no sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2783196e8aa85f674bcdd48993f83882
https://pubmed.ncbi.nlm.nih.gov/15520876
https://pubmed.ncbi.nlm.nih.gov/15520876
Autor:
Istvan Köves, Ferenc Czeglédi, Tibor Kovács, Judit Kralovánszky, Zsolt Orosz, Katalin Tóth, Barna Budai, Csilla Katona, Lehel Hullán, András Jeney, Pál Rahóty
Publikováno v:
Oncology. 62(2)
The aim of the present study was to determine the relative intratumoral activity of two pyrimidine biosynthetic enzymes, i.e. thymidylate synthase (TS) and thymidine kinase (TK), in human colorectal cancers to compare their possible relationship with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b540e0bf901b78b4004eeffac07920
https://pubmed.ncbi.nlm.nih.gov/11914603
https://pubmed.ncbi.nlm.nih.gov/11914603
Autor:
Zsolt Orosz, Judit Kralovánszky, Ferenc Czeglédi, Eszter Szabó, István Láng, Vilmos Adleff, Zsolt Horváth, Barna Budai, Erika Hitre, A. Gazdag
Publikováno v:
Journal of Clinical Oncology. 22:3581-3581
3581 Background: TS, the target enzym of 5-FU has a 28 bp polymorphism in the promoter region containing commonly double of triple tandem repeats of a 28 bp sequence (2R or 3R), and a 6bp ins/del polymorphism on the 3'UTR. Our aim was to study the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::492b4301a44886726c5901b0b42a5b79
https://doi.org/10.1200/jco.2004.22.90140.3581
https://doi.org/10.1200/jco.2004.22.90140.3581